JP2020523323A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020523323A5 JP2020523323A5 JP2019567989A JP2019567989A JP2020523323A5 JP 2020523323 A5 JP2020523323 A5 JP 2020523323A5 JP 2019567989 A JP2019567989 A JP 2019567989A JP 2019567989 A JP2019567989 A JP 2019567989A JP 2020523323 A5 JP2020523323 A5 JP 2020523323A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- divalent
- streptococcus pneumoniae
- polysaccharides
- capsular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001282 polysaccharide Polymers 0.000 claims 79
- 239000005017 polysaccharide Substances 0.000 claims 79
- 150000004676 glycans Chemical class 0.000 claims 77
- 239000000203 mixture Substances 0.000 claims 55
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 36
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 36
- 102000014914 Carrier Proteins Human genes 0.000 claims 27
- 108010078791 Carrier Proteins Proteins 0.000 claims 27
- 230000002163 immunogen Effects 0.000 claims 22
- 241000606768 Haemophilus influenzae Species 0.000 claims 8
- 241000701806 Human papillomavirus Species 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 229940047650 haemophilus influenzae Drugs 0.000 claims 5
- -1 35B polysaccharides Chemical class 0.000 claims 4
- 108010083528 Adenylate Cyclase Toxin Proteins 0.000 claims 4
- 241000700721 Hepatitis B virus Species 0.000 claims 4
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 4
- 239000002775 capsule Substances 0.000 claims 4
- 229960000814 tetanus toxoid Drugs 0.000 claims 4
- 241000588650 Neisseria meningitidis Species 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 229940035032 monophosphoryl lipid a Drugs 0.000 claims 3
- 241000588832 Bordetella pertussis Species 0.000 claims 2
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims 2
- 101710132601 Capsid protein Proteins 0.000 claims 2
- 241000588655 Moraxella catarrhalis Species 0.000 claims 2
- 201000005702 Pertussis Diseases 0.000 claims 2
- 241001505901 Streptococcus sp. 'group A' Species 0.000 claims 2
- 241000193990 Streptococcus sp. 'group B' Species 0.000 claims 2
- 229940124613 TLR 7/8 agonist Drugs 0.000 claims 2
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims 2
- 230000001588 bifunctional effect Effects 0.000 claims 2
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 2
- 239000001506 calcium phosphate Substances 0.000 claims 2
- 235000011010 calcium phosphates Nutrition 0.000 claims 2
- 229960003983 diphtheria toxoid Drugs 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 239000002502 liposome Substances 0.000 claims 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 2
- 229930182490 saponin Natural products 0.000 claims 2
- 150000007949 saponins Chemical class 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 2
- FBFJOZZTIXSPPR-UHFFFAOYSA-N 1-(4-aminobutyl)-2-(ethoxymethyl)imidazo[4,5-c]quinolin-4-amine Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CCCCN)C3=C(N)N=C21 FBFJOZZTIXSPPR-UHFFFAOYSA-N 0.000 claims 1
- 101710118506 69 kDa protein Proteins 0.000 claims 1
- 241000588807 Bordetella Species 0.000 claims 1
- 201000009906 Meningitis Diseases 0.000 claims 1
- 241000588653 Neisseria Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 108010067390 Viral Proteins Proteins 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000002158 endotoxin Substances 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 229920006008 lipopolysaccharide Polymers 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 150000004804 polysaccharides Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000006850 spacer group Chemical group 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762517905P | 2017-06-10 | 2017-06-10 | |
| US62/517,905 | 2017-06-10 | ||
| PCT/US2018/036868 WO2018227177A1 (en) | 2017-06-10 | 2018-06-11 | Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020523323A JP2020523323A (ja) | 2020-08-06 |
| JP2020523323A5 true JP2020523323A5 (enExample) | 2021-04-30 |
| JP7132954B2 JP7132954B2 (ja) | 2022-09-07 |
Family
ID=64562792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019567989A Active JP7132954B2 (ja) | 2017-06-10 | 2018-06-11 | 改善された免疫原性及び結合活性を提供する２価又は多価コンジュゲート多糖を含む多価コンジュゲートワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10688170B2 (enExample) |
| EP (1) | EP3634481A4 (enExample) |
| JP (1) | JP7132954B2 (enExample) |
| KR (3) | KR20240018698A (enExample) |
| CN (2) | CN118356485A (enExample) |
| AU (1) | AU2018280272C1 (enExample) |
| BR (1) | BR112019026192B1 (enExample) |
| CA (1) | CA3066911C (enExample) |
| MX (2) | MX2019014829A (enExample) |
| MY (1) | MY198400A (enExample) |
| WO (1) | WO2018227177A1 (enExample) |
| ZA (1) | ZA201908528B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3283102A4 (en) * | 2015-04-16 | 2018-10-03 | Inventprise, LLC. | Bordetella pertussis immunogenic vaccine compositions |
| KR20250058066A (ko) * | 2015-07-21 | 2025-04-29 | 화이자 인코포레이티드 | 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도 |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| MX2019014829A (es) | 2017-06-10 | 2020-08-17 | Inventprise Llc | Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas. |
| EP3720483B1 (en) | 2017-12-06 | 2025-11-19 | Merck Sharp & Dohme LLC | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| US20220016229A1 (en) * | 2018-12-12 | 2022-01-20 | Pfizer Inc. | Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof |
| EP3897705A2 (en) | 2018-12-19 | 2021-10-27 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| CA3142692A1 (en) * | 2019-06-05 | 2020-12-10 | Merck Sharp & Dohme Corp. | An immunogenic serotype 35b pneumococcal polysaccharide-protein conjugate and conjugation process for making the same |
| CN110804097B (zh) * | 2019-10-30 | 2021-02-26 | 云南沃森生物技术股份有限公司 | 一种同时制备两种单克隆抗体的方法 |
| KR20220146451A (ko) * | 2020-01-17 | 2022-11-01 | 인벤트프라이즈 엘엘씨 | 다가 스트렙토코커스 백신 |
| CN111643661A (zh) * | 2020-06-08 | 2020-09-11 | 王竹林 | 新型免疫佐剂、化合物及其应用 |
| US12053515B2 (en) | 2020-08-10 | 2024-08-06 | Inventprise, Inc. | Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F |
| CA3200602A1 (en) * | 2020-11-04 | 2022-05-12 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
| CN113173977B (zh) * | 2021-05-12 | 2024-03-29 | 江苏坤力生物制药有限责任公司 | 一种双功能抗原、其制备方法及应用 |
| CN115721709A (zh) * | 2021-08-27 | 2023-03-03 | 康希诺生物股份公司 | 一种肺炎球菌结合疫苗制备方法 |
| GB2614916A (en) | 2022-01-25 | 2023-07-26 | Optivalent Ltd | Intradermal vaccine complement |
| WO2023176206A1 (ja) * | 2022-03-18 | 2023-09-21 | デンカ株式会社 | リンカーにより連結されたカプシドタンパク質を含むウイルス様粒子 |
| CN117643624A (zh) * | 2024-01-30 | 2024-03-05 | 成都康华生物制品股份有限公司 | 一种双价多糖结合疫苗的制备方法及双价多糖结合疫苗 |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| US5360897A (en) | 1981-08-31 | 1994-11-01 | The University Of Rochester | Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4686102A (en) | 1984-04-12 | 1987-08-11 | American Cyanamid Company | Multivalent pneumococcal vaccine and preparation thereof |
| CA2059692C (en) | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
| CA2059693C (en) | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| US5371197A (en) | 1991-09-24 | 1994-12-06 | Merck & Co., Inc. | Protein-dimeric polysaccharide conjugate vaccine |
| US5849301A (en) | 1993-09-22 | 1998-12-15 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents |
| US5565204A (en) | 1994-08-24 | 1996-10-15 | American Cyanamid Company | Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| US5681570A (en) | 1995-01-12 | 1997-10-28 | Connaught Laboratories Limited | Immunogenic conjugate molecules |
| US5866132A (en) | 1995-06-07 | 1999-02-02 | Alberta Research Council | Immunogenic oligosaccharide compositions |
| FR2763244B1 (fr) | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| US6224880B1 (en) | 1997-09-24 | 2001-05-01 | Merck & Co., Inc. | Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines |
| US5965714A (en) | 1997-10-02 | 1999-10-12 | Connaught Laboratories, Inc. | Method for the covalent attachment of polysaccharides to protein molecules |
| US7018637B2 (en) | 1998-02-23 | 2006-03-28 | Aventis Pasteur, Inc | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| US6903184B1 (en) | 1998-03-02 | 2005-06-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| NZ530277A (en) | 1998-04-07 | 2005-08-26 | Medimmune Inc | Derivatives of pneumococcal choline binding proteins for vaccines |
| EP1034792A1 (en) | 1999-03-11 | 2000-09-13 | Pasteur Merieux Serums Et Vaccins | Intranasal delivery of pneumococcal polysaccharide vaccines |
| CA2366152A1 (en) | 1999-03-19 | 2000-09-28 | Smithkline Beecham Biologicals S.A. | Streptococcus pneumoniae vaccine |
| FR2806304B1 (fr) | 2000-03-17 | 2002-05-10 | Aventis Pasteur | Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie |
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| GB0130215D0 (en) | 2001-12-18 | 2002-02-06 | Glaxosmithkline Biolog Sa | Vaccine |
| NZ536859A (en) | 2002-05-14 | 2007-11-30 | Chiron Srl | Mucosal combination vaccines for bacterial meningitis |
| AU2003245648A1 (en) | 2002-06-20 | 2004-01-06 | University Of Maryland Biotechnology Institute | Scaffolded maleimide clusters for multivalent peptide assembly |
| US20040096461A1 (en) * | 2002-07-30 | 2004-05-20 | Baxter Healthcare Corporation | Chimeric multivalent polysaccharide conjugate vaccines |
| MXPA05009579A (es) | 2003-03-13 | 2005-11-17 | Glaxosmithkline Biolog Sa | Proceso de purificacion para citolisina bacteriana. |
| US8048432B2 (en) | 2003-08-06 | 2011-11-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Polysaccharide-protein conjugate vaccines |
| AU2004263135B2 (en) | 2003-08-06 | 2010-11-25 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Polysaccharide-protein conjugate vaccines |
| US20050118199A1 (en) | 2003-10-07 | 2005-06-02 | Esser Mark T. | Process for covalently conjugating polysaccharides to microspheres or biomolecules |
| WO2005120563A2 (en) * | 2004-06-04 | 2005-12-22 | Pharmexa Inc. | Induction of an immune response against streptococcus pneumoniae polysaccharides |
| GB0428394D0 (en) | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
| IL308456A (en) | 2005-04-08 | 2024-01-01 | Wyeth Llc | A multivalent pneumomuroral protein-polysaccharide conjugate preparation |
| US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| CN102973929B (zh) | 2005-09-01 | 2017-04-26 | 诺华疫苗和诊断有限两合公司 | 含血清群c脑膜炎球菌的多价疫苗 |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| JP5792920B2 (ja) | 2005-12-22 | 2015-10-14 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| JP5285431B2 (ja) | 2005-12-28 | 2013-09-11 | ザ ユーエイビー リサーチ ファウンデイション | 肺炎球菌血清型 |
| AU2006336520B2 (en) | 2005-12-28 | 2011-09-15 | The Uab Research Foundation | Pneumococcal serotypes |
| US8575319B2 (en) | 2006-03-10 | 2013-11-05 | The Regents Of The University Of California | Cleavable vaccine compositions and uses thereof and methods of making and using the same |
| KR101838938B1 (ko) | 2006-03-17 | 2018-03-15 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 | 복합 다가 면역원성 콘쥬게이트의 제조 방법 |
| AR060187A1 (es) | 2006-03-30 | 2008-05-28 | Glaxosmithkline Biolog Sa | Composicion inmunogenica |
| US20070253985A1 (en) | 2006-04-26 | 2007-11-01 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
| US8808707B1 (en) | 2006-05-08 | 2014-08-19 | Wyeth Llc | Pneumococcal dosing regimen |
| KR101446238B1 (ko) | 2006-08-07 | 2014-10-01 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 단백질 매트릭스 백신 및 그의 제조방법 및 백신 투여방법 |
| HUE039169T2 (hu) | 2007-03-23 | 2018-12-28 | Wyeth Llc | Rövidített tisztítási eljárás Streptococcus pneumoniae tok-poliszacharidok elõállítására |
| CA2692069C (en) | 2007-06-20 | 2016-10-18 | Baxter Healthcare S.A. | Modified polysaccharides for conjugate vaccines |
| EA200901578A1 (ru) | 2007-06-26 | 2010-08-30 | Глаксосмитклайн Байолоджикалс С.А. | Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae |
| GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| US8226959B2 (en) | 2008-02-01 | 2012-07-24 | Newcastle Innovation Pty Ltd | Vaccine compositions |
| EP2108656A1 (en) | 2008-03-19 | 2009-10-14 | Beninati, Concetta | Antigenic protein fragments of streptococcus pneumoniae |
| WO2010080486A2 (en) | 2008-12-18 | 2010-07-15 | Wyeth Llc | Method for controlling streptococcus pneumoniae serotype 19a polysaccharide molecular weight |
| DK2424562T3 (en) | 2009-04-30 | 2015-12-07 | Coley Pharm Group Inc | Pneumococcal vaccine and uses thereof |
| US20120135037A1 (en) | 2009-06-01 | 2012-05-31 | Mizel Steven B | Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
| CA2773690A1 (en) | 2009-09-09 | 2011-03-17 | Matrivax Research & Development Corp. | Protein matrix vaccines of improved immunogenicity |
| TW201136603A (en) * | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| EP3626263A1 (en) | 2010-06-04 | 2020-03-25 | Wyeth LLC | Vaccine formulations |
| RU2632651C2 (ru) | 2011-05-11 | 2017-10-06 | Чилдрен'С Медикал Сентер Корпорейшн | Модифицированный биотин-связывающий белок, слитые белки на его основе и их применение |
| BR112013031028A2 (pt) | 2011-06-03 | 2016-11-29 | 3M Innovative Properties Co | conectores heterobifuncionais com segmentos de polietileno glicol e conjugados de modificadores de resposta imunológica feitos a partir deles |
| CA2879272A1 (en) | 2012-07-16 | 2014-01-23 | Robert G.K. DONALD | Saccharides and uses thereof |
| PT2885007T (pt) | 2012-08-16 | 2018-12-10 | Pfizer | Processos e composições de glicoconjugação |
| CN103656631B (zh) * | 2012-09-24 | 2015-08-19 | 北京科兴中维生物技术有限公司 | 多价肺炎球菌荚膜多糖-蛋白缀合物组合物及其制备方法 |
| GB201218660D0 (en) * | 2012-10-17 | 2012-11-28 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| RU2672053C2 (ru) | 2012-12-20 | 2018-11-09 | Пфайзер Инк. | Способ гликоконъюгации |
| ITMI20130142A1 (it) | 2013-01-31 | 2014-08-01 | Biosynth Srl | Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati |
| US20150079132A1 (en) | 2013-09-17 | 2015-03-19 | Path | Evoking protection against streptotoccus pneumoniae incorporating b-cell and t-cell pneumococcal protein antigens and pneumococcal polysaccharides delivered concomitantly |
| IL312327B2 (en) | 2014-01-21 | 2026-02-01 | Pfizer | Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses |
| FI3583947T3 (fi) | 2014-01-21 | 2023-10-12 | Pfizer | Streptococcus pneumoniaen kapselipolysakkaridit ja niiden konjugaatit |
| BR112016015835B1 (pt) | 2014-01-21 | 2023-12-26 | Pfizer Inc | Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae |
| ES2930318T3 (es) | 2014-02-14 | 2022-12-09 | Pfizer | Conjugados glucoproteicos inmunogénicos |
| GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
| CN104069504B (zh) | 2014-05-11 | 2019-09-24 | 江苏康泰生物医学技术有限公司 | 一种增强多糖蛋白结合物免疫原性的方法 |
| US20150344530A1 (en) | 2014-05-29 | 2015-12-03 | Subhash V. Kapre | Synthetic Peptides as Carriers for Conjugation with Polysaccharides |
| TN2017000126A1 (en) | 2014-10-09 | 2018-10-19 | Msd Wellcome Trust Hilleman Laboratories Pvt Ltd | An improved process of conjugation and novel synthetic oligosaccharide- protein conjugates obtained thereof |
| RS61440B1 (sr) | 2015-06-23 | 2021-03-31 | Biological E Ltd | Multivalentna pneumokokna konjugatna vakcina |
| KR20250058066A (ko) | 2015-07-21 | 2025-04-29 | 화이자 인코포레이티드 | 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도 |
| US10786561B2 (en) | 2015-11-20 | 2020-09-29 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
| MX2019014829A (es) | 2017-06-10 | 2020-08-17 | Inventprise Llc | Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas. |
-
2018
- 2018-06-11 MX MX2019014829A patent/MX2019014829A/es unknown
- 2018-06-11 JP JP2019567989A patent/JP7132954B2/ja active Active
- 2018-06-11 AU AU2018280272A patent/AU2018280272C1/en active Active
- 2018-06-11 MY MYPI2019007342A patent/MY198400A/en unknown
- 2018-06-11 CN CN202410331847.1A patent/CN118356485A/zh active Pending
- 2018-06-11 KR KR1020247004036A patent/KR20240018698A/ko active Pending
- 2018-06-11 EP EP18813972.9A patent/EP3634481A4/en active Pending
- 2018-06-11 US US16/004,743 patent/US10688170B2/en active Active
- 2018-06-11 CA CA3066911A patent/CA3066911C/en active Active
- 2018-06-11 KR KR1020247004035A patent/KR20240018697A/ko active Pending
- 2018-06-11 BR BR112019026192-3A patent/BR112019026192B1/pt active IP Right Grant
- 2018-06-11 KR KR1020207000802A patent/KR102634811B1/ko active Active
- 2018-06-11 CN CN201880051935.9A patent/CN111132691A/zh active Pending
- 2018-06-11 WO PCT/US2018/036868 patent/WO2018227177A1/en not_active Ceased
-
2019
- 2019-12-09 MX MX2023009362A patent/MX2023009362A/es unknown
- 2019-12-20 ZA ZA2019/08528A patent/ZA201908528B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU750788B2 (en) | Vaccine | |
| JP2005508849A5 (enExample) | ||
| JP7132954B2 (ja) | 改善された免疫原性及び結合活性を提供する２価又は多価コンジュゲート多糖を含む多価コンジュゲートワクチン | |
| JP2004501873A5 (enExample) | ||
| JP2014506916A5 (enExample) | ||
| JP2010163453A5 (enExample) | ||
| JP2008543908A5 (enExample) | ||
| JP2008543907A5 (enExample) | ||
| HRP20110685T1 (hr) | Cjepivo od konjugata pneumokoknog polisaharida | |
| ZA200107638B (en) | Vaccine. | |
| TH55565A (th) | องค์ประกอบวัคซีน | |
| MXPA01009455A (en) | Vaccine | |
| HK1114012A (en) | Vaccine |